StockData
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC

ABVC BIOPHARMA, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.91−0.01 (-0.86%)

Close on Oct 19, 2026

Market cap
$23.71M
P/E (TTM)
–
Dividend yield
–

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
1M
Shares held, 13F filers
Institutional holders
15
7 new, 5 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Lind Global Fund II LP1,325,0009.90%13G (passive) amendmentDec 31, 2024
Eugene Jiang131,15918.50%13D (active) amendmentJul 10, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ABVCValueChange% of portfolio
Vanguard Capital Management LLC374,499–$591.71K+183,9250.00%
Geode Capital Management, LLC228,042–$360.38K+6,8730.00%
Vanguard Fiduciary Trust Co97,363–$153.83K–0.00%
State Street Corp72,800–$115.02K–0.00%
Citadel Advisors LLC72,091–$113.90KNew0.00%
BlackRock, Inc.56,442–$89.18K–0.00%
Northern Trust Corp48,643–$76.86K+16,5560.00%
XTX Topco Ltd48,276–$76.28KNew0.00%
Panagora Asset Management Inc36,682–$57.96KNew0.00%
UBS Group AG34,123–$53.91K+32,3520.00%
Jane Street Group, LLC20,059–$31.69KNew0.00%
Citigroup Inc540–$853New0.00%
LifeSteps Financial, Inc.300–$474New0.00%
Royal Bank of Canada17–$0–0.00%
Caitong International Asset Management Co., Ltd6–$9New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 2026151M7 / 40 / 50M0M
Q1 2026131M6 / 22 / 60M0M
Q4 2025141M2 / 82 / 20M0M
Q3 2025141M6 / 62 / 10M0M
Q2 202590M1 / 52 / 20M0M
Q1 2025100M0 / 52 / 30M0M
Q4 2024130M4 / 51 / 00M0M
Q3 202490M1 / 22 / 20M0M
Q2 2024110M5 / 21 / 20M0M
Q1 202480M2 / 40 / 20M0M
Q4 202380M1 / 31 / 20M0M
Q3 202390M9 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of ABVCValue% of fundAs of
Vanguard Extended Market Index Fund208,279–$329.08K0.00%Jun 30, 2026
Vanguard Total Stock Market Index Fund115,243–$182.08K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund109,835–$154.87K0.00%May 31, 2026
Fidelity Total Market Index Fund31,053–$43.78K0.00%May 31, 2026
Fidelity Series Total Market Index Fund28,657–$40.41K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund6,128–$8.64K0.00%May 31, 2026
Blackstone Alternative Multi-Strategy Fund-100–-$158-0.00%Jun 30, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Kevin Patrick Stolz
VP & Controller
Jan 27, 2012Award+6,250––6,250
Joseph Nirta
Director
May 11, 2010Buy+10,000$0.15$1.50K10,000
Joseph Nirta
Director
Mar 22, 2010Buy+2,000$0.26$5202,000
J.B. Smith
Director, 10% owner
Nov 13, 2009Buy+714,286$50000.00$35.71B16,585,538
Daniel V. Iannotti
VP, General Counsel & Secretar
Sep 21, 2009Award+70,000$0.51$35.70K400,000
Frank Thomas Krotine
President & COO
Sep 21, 2009Award+169,000$0.51$86.19K510,217
Robert G. Crockett
Chief Executive Officer
Sep 21, 2009Award+670,000$0.51$341.70K1,000,000
J.B. Smith
Director, 10% owner
Aug 31, 2009Buy+192,308$50000.00$9.62B18,430,752
J.B. Smith
Director, 10% owner
Aug 31, 2009Buy+192,308$50000.00$9.62B17,349,752
J.B. Smith
Director, 10% owner
Aug 19, 2009Gift−300,000––17,575,000
J.B. Smith
Director, 10% owner
Jun 10, 2009Buy+20$20000.00$400.00K336
J.B. Smith
Director, 10% owner
Jun 2, 2009Buy+55$55000.00$3.03M2,436
J.B. Smith
Director, 10% owner
Jun 2, 2009Buy+40$40000.00$1.60M316
J.B. Smith
Director, 10% owner
Apr 29, 2009Buy+34$34000.00$1.16M2,381
J.B. Smith
Director, 10% owner
Apr 14, 2009Buy+21$21000.00$441.00K2,347
J.B. Smith
Director, 10% owner
Mar 26, 2009Buy+80$80000.00$6.40M2,326
Sally Judith Ramsey
Director, 10% owner
Mar 26, 2009Buy+80$80000.00$6.40M2,326
J.B. Smith
Director, 10% owner
Mar 10, 2009Buy+23$23000.00$529.00K2,246
J.B. Smith
Director, 10% owner
Feb 26, 2009Buy+40$40000.00$1.60M2,223
J.B. Smith
Director, 10% owner
Feb 11, 2009Buy+30$30000.00$900.00K2,158
J.B. Smith
Director, 10% owner
Feb 10, 2009Other+24––2,128
Richard Dean Stromback
Director, 10% owner
Jan 23, 2009Sale−4,000,000$1.00$4.00M10,637,500
J.B. Smith
Director, 10% owner
Jan 23, 2009Buy+4,000,000––5,500,000
Richard Dean Stromback
Director, 10% owner
Jan 23, 2009Sale−4,000,000$1.00$4.00M10,637,500
J.B. Smith
Director, 10% owner
Jan 23, 2009Buy+4,000,000$1.00$4.00M5,500,000
J.B. Smith
Director
Sep 26, 2008Buy+750$1000.00$750.00K2,010
Richard Dean Stromback
CEO, Director, 10% owner
Aug 18, 2008Sale−1,500,000––14,637,500
Sally Judith Ramsey
VP New Product Development
Jul 30, 2007Buy+3,000,000––3,000,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.